Thomas M. Lanigan

1.2k total citations
31 papers, 864 citations indexed

About

Thomas M. Lanigan is a scholar working on Molecular Biology, Oncology and Genetics. According to data from OpenAlex, Thomas M. Lanigan has authored 31 papers receiving a total of 864 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 6 papers in Oncology and 6 papers in Genetics. Recurrent topics in Thomas M. Lanigan's work include SARS-CoV-2 and COVID-19 Research (4 papers), Immunotherapy and Immune Responses (4 papers) and Neuropeptides and Animal Physiology (3 papers). Thomas M. Lanigan is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (4 papers), Immunotherapy and Immune Responses (4 papers) and Neuropeptides and Animal Physiology (3 papers). Thomas M. Lanigan collaborates with scholars based in United States, Japan and Netherlands. Thomas M. Lanigan's co-authors include Andrew F. Russo, Roland Hilgarth, Huira C. Kopera, Michael Clark, Blake J. Roessler, Thomas L. Saunders, Shinsuke Ohba, David A. Fox, Jeffrey H. Ruth and Albert Liu and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Blood.

In The Last Decade

Thomas M. Lanigan

31 papers receiving 856 citations

Peers

Countries citing papers authored by Thomas M. Lanigan

Since Specialization

Citations

This map shows the geographic impact of Thomas M. Lanigan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas M. Lanigan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas M. Lanigan more than expected).

Fields of papers citing papers by Thomas M. Lanigan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas M. Lanigan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas M. Lanigan. The network helps show where Thomas M. Lanigan may publish in the future.

Co-authorship network of co-authors of Thomas M. Lanigan

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas M. Lanigan. A scholar is included among the top collaborators of Thomas M. Lanigan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas M. Lanigan. Thomas M. Lanigan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Effects of intracardiac delivery of aldehyde dehydrogenase 2 gene in myocardial salvage 2022 ·Gene Therapy ·(unknown), Bipradas Roy, Pamela Harding, Thomas M. Lanigan, Roland Hilgarth, Rajarajan A. Thandavarayan, Suresh S. Palaniyandi	3
2	Engineered Multivalent Nanobodies Potently and Broadly Neutralize SARS‐CoV‐2 Variants 2021 ·Advanced Therapeutics ·Jennifer M. Zupancic, John S. Schardt, Alec A. Desai, Emily K. Makowski, Matthew D. Smith, (unknown), Mayara Garcia de Mattos Barbosa, Marília Cascalho, Thomas M. Lanigan, Peter M. Tessier	30
3	CD6 is a target for cancer immunotherapy 2021 ·JCI Insight ·Jeffrey H. Ruth, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), M. Asif Amin, Phillip L. Campbell, Pei‐Suen Tsou, Yang Mao‐Draayer, Qi Wu, Thomas M. Lanigan, Venkateshwar G. Keshamouni, Nora G. Singer, Feng Lin, David A. Fox	34
4	IgV somatic mutation of human anti–SARS-CoV-2 monoclonal antibodies governs neutralization and breadth of reactivity 2021 ·JCI Insight ·Mayara Garcia de Mattos Barbosa, Hui Liu, (unknown), Greg Shelley, Evan T. Keller, Brian T. Emmer, (unknown), David Ginsburg, Andrew A. Kennedy, Andrew W. Tai, Christiane E. Wobus, (unknown), Thomas M. Lanigan, Milagros Samaniego, Wenzhao Meng, Aaron M. Rosenfeld, Eline T. Luning Prak, Jeffrey L. Platt, Marília Cascalho	8
5	Directed evolution of potent neutralizing nanobodies against SARS-CoV-2 using CDR-swapping mutagenesis 2021 ·Cell chemical biology ·Jennifer M. Zupancic, Alec A. Desai, John S. Schardt, (unknown), Emily K. Makowski, Matthew D. Smith, Andrew A. Kennedy, Mayara Garcia de Mattos Barbosa, Marília Cascalho, Thomas M. Lanigan, Andrew W. Tai, Peter M. Tessier	32
6	Discovery and characterization of high-affinity, potent SARS-CoV-2 neutralizing antibodies via single B cell screening 2021 ·Scientific Reports ·John S. Schardt, (unknown), Alec A. Desai, Kyong Soo Park, Jennifer M. Zupancic, Emily K. Makowski, Matthew D. Smith, Hongwei Chen, Mayara Garcia de Mattos Barbosa, Marília Cascalho, Thomas M. Lanigan, James J. Moon, Peter M. Tessier	16
7	Principles of Genetic Engineering 2020 ·Genes ·Thomas M. Lanigan, Huira C. Kopera, Thomas L. Saunders	49
8	Real time visualization of cancer cell death, survival and proliferation using fluorochrome-transfected cells in an IncuCyte® imaging system 2020 ·Journal of Biological Methods ·Thomas M. Lanigan, (unknown), (unknown), (unknown), Phillip L. Campbell, David A. Fox, Jeffrey H. Ruth	20
9	Optimization of overlap extension PCR for efficient transgene construction 2019 ·MethodsX ·Roland Hilgarth, Thomas M. Lanigan	52
10	Durable targeting of B-lymphocytes in living mice 2018 ·Scientific Reports ·Marília Cascalho, (unknown), Adam R. Lefferts, (unknown), Thomas M. Lanigan, Joseph T. Decker, Lonnie D. Shea, Jeffrey L. Platt	1
11	A leptin-regulated circuit controls glucose mobilization during noxious stimuli 2017 ·Journal of Clinical Investigation ·Jonathan N. Flak, Deanna M. Arble, Warren W. Pan, Christa M. Patterson, Thomas M. Lanigan, Paulette B. Goforth, (unknown), (unknown), Donald A. Morgan, Margaret B. Allison, John F. Hayes, Eva L. Feldman, Randy J. Seeley, David P. Olson, Kamal Rahmouni, Martin G. Myers	29
12	GATA-3 expression identifies a high-risk subset of PTCL, NOS with distinct molecular and clinical features 2014 ·Blood ·Tianjiao Wang, Andrew L. Feldman, David A. Wada, Ye Lu, Avery Polk, (unknown), Kay M. Ristow, Thomas M. Habermann, Dafydd G. Thomas, Steven C. Ziesmer, Linda Wellik, Thomas M. Lanigan, Thomas E. Witzig, Mark R. Pittelkow, Nathanael G. Bailey, Alexandra C. Hristov, Megan S. Lim, Stephen M. Ansell, Ryan A. Wilcox	132
13	Leptin receptor JAK2/STAT3 signaling modulates expression of Frizzled receptors in articular chondrocytes 2010 ·Osteoarthritis and Cartilage ·Shinsuke Ohba, Thomas M. Lanigan, Blake J. Roessler	35
14	Development and characterization of a canine oral mucosa equivalent in a serum‐free environment 2004 ·Journal of Biomedical Materials Research Part A ·Junhui Song, Kenji Izumi, Thomas M. Lanigan, Stephen E. Feinberg	10
15	Human homologue of Drosophila CNK interacts with Ras effector proteins Raf and Rlf ¹ 2003 ·The FASEB Journal ·Thomas M. Lanigan, Albert Liu, Yang Z. Huang, Lin Mei, Ben Margolis, Kun‐Liang Guan	45
16	T1 efficacy of EVP‐ABD: A potential manganese‐based MR contrast agent for hepatic vascular and tissue phase imaging 2002 ·Journal of Magnetic Resonance Imaging ·Chengguo Zuo, Peter R. Seoane, Thomas M. Lanigan, (unknown), Pottumarthi V. Prasad, Pippa Storey, (unknown), Neil M. Rofsky	6
17	Requirement of the MASH-1 transcription factor for neuroendocrine differentiation of thyroid C cells 1998 ·Journal of Neurobiology ·Thomas M. Lanigan, (unknown), Andrew F. Russo	61
18	Binding of Upstream Stimulatory Factor and a Cell-specific Activator to the Calcitonin/Calcitonin Gene-related Peptide Enhancer 1997 ·Journal of Biological Chemistry ·Thomas M. Lanigan, Andrew F. Russo	45
19	Retinoic Acid Repression of Cell-Specific Helix-Loop-Helix-Octamer Activation of the Calcitonin/Calcitonin Gene-Related Peptide Enhancer 1993 ·Molecular and Cellular Biology ·Thomas M. Lanigan, (unknown), Andrew F. Russo	21
20	Dihydrofolate reductase from Escherichia coli: probing the role of aspartate-27 and phenylalanine-137 in enzyme conformation and the binding of NADPH 1990 ·Biochemistry ·Susan M. J. Dunn, Thomas M. Lanigan, Elizabeth E. Howell	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact